Diffuse Colour Discrimination as Marker of Afferent Visual System Dysfunction in Amyotrophic Lateral Sclerosis

Abnormalities of the inner and intermediate retinal structures in patients with amyotrophic lateral sclerosis (ALS) have been described using optical coherence tomography and histopathology. Colour vision is a potential marker of these structural changes. The purpose of this study is to test the hyp...

Full description

Saved in:
Bibliographic Details
Published inNeuro-ophthalmology (Amsterdam : Aeolus Press. 1980) Vol. 41; no. 6; pp. 310 - 314
Main Authors Boven, Lindsay, Jiang, Qin Li, Moss, Heather E.
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 02.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abnormalities of the inner and intermediate retinal structures in patients with amyotrophic lateral sclerosis (ALS) have been described using optical coherence tomography and histopathology. Colour vision is a potential marker of these structural changes. The purpose of this study is to test the hypothesis that colour vision impairment is associated with ALS. Monocular (right eye) colour vision was assessed in subjects with definite or probable ALS (n = 25, aged 50-80 years) and control (n = 21, aged 46-89 years) subjects with corrected near visual acuity of at least 20/40 using the L'Anthony D15 color test (desaturated), scored by c-index, a measure of diffuse colour discrimination. Of ALS subjects, 16/25 (64%) had impaired colour vision (c-index >1.8). Comparing with our normal subjects and accounting for age, 72% (n = 18) of ALS subjects had colour vision below the 50th percentile, 52% (n = 13) had colour vision below the 25th percentile, 24% (n = 6) had colour vision below the 10th percentile, and 8% (n = 2) had colour vision below the 2nd percentile. In multivariate models of ln(c-index) and age, the intercept was higher and the slope was flatter in ALS subjects, suggesting that colour vision deficits are more prominent in younger ALS patients. Diffuse colour discrimination deficits are detected in ALS subjects at younger ages than in control subjects. Further study is needed to confirm these findings and to determine if the ALS colour discrimination abnormalities correlate with structural markers of retinal involvement and ALS disease severity.
AbstractList Abnormalities of the inner and intermediate retinal structures in patients with amyotrophic lateral sclerosis (ALS) have been described using optical coherence tomography and histopathology. Colour vision is a potential marker of these structural changes. The purpose of this study is to test the hypothesis that colour vision impairment is associated with ALS. Monocular (right eye) colour vision was assessed in subjects with definite or probable ALS (n = 25, aged 50-80 years) and control (n = 21, aged 46-89 years) subjects with corrected near visual acuity of at least 20/40 using the L'Anthony D15 color test (desaturated), scored by c-index, a measure of diffuse colour discrimination. Of ALS subjects, 16/25 (64%) had impaired colour vision (c-index >1.8). Comparing with our normal subjects and accounting for age, 72% (n = 18) of ALS subjects had colour vision below the 50th percentile, 52% (n = 13) had colour vision below the 25th percentile, 24% (n = 6) had colour vision below the 10th percentile, and 8% (n = 2) had colour vision below the 2nd percentile. In multivariate models of ln(c-index) and age, the intercept was higher and the slope was flatter in ALS subjects, suggesting that colour vision deficits are more prominent in younger ALS patients. Diffuse colour discrimination deficits are detected in ALS subjects at younger ages than in control subjects. Further study is needed to confirm these findings and to determine if the ALS colour discrimination abnormalities correlate with structural markers of retinal involvement and ALS disease severity.Abnormalities of the inner and intermediate retinal structures in patients with amyotrophic lateral sclerosis (ALS) have been described using optical coherence tomography and histopathology. Colour vision is a potential marker of these structural changes. The purpose of this study is to test the hypothesis that colour vision impairment is associated with ALS. Monocular (right eye) colour vision was assessed in subjects with definite or probable ALS (n = 25, aged 50-80 years) and control (n = 21, aged 46-89 years) subjects with corrected near visual acuity of at least 20/40 using the L'Anthony D15 color test (desaturated), scored by c-index, a measure of diffuse colour discrimination. Of ALS subjects, 16/25 (64%) had impaired colour vision (c-index >1.8). Comparing with our normal subjects and accounting for age, 72% (n = 18) of ALS subjects had colour vision below the 50th percentile, 52% (n = 13) had colour vision below the 25th percentile, 24% (n = 6) had colour vision below the 10th percentile, and 8% (n = 2) had colour vision below the 2nd percentile. In multivariate models of ln(c-index) and age, the intercept was higher and the slope was flatter in ALS subjects, suggesting that colour vision deficits are more prominent in younger ALS patients. Diffuse colour discrimination deficits are detected in ALS subjects at younger ages than in control subjects. Further study is needed to confirm these findings and to determine if the ALS colour discrimination abnormalities correlate with structural markers of retinal involvement and ALS disease severity.
Abnormalities of the inner and intermediate retinal structures in patients with amyotrophic lateral sclerosis (ALS) have been described using optical coherence tomography and histopathology. Colour vision is a potential marker of these structural changes. The purpose of this study is to test the hypothesis that colour vision impairment is associated with ALS. Monocular (right eye) colour vision was assessed in subjects with definite or probable ALS ( n = 25, aged 50–80 years) and control ( n = 21, aged 46–89 years) subjects with corrected near visual acuity of at least 20/40 using the L’Anthony D15 color test (desaturated), scored by c-index, a measure of diffuse colour discrimination. Of ALS subjects, 16/25 (64%) had impaired colour vision (c-index >1.8). Comparing with our normal subjects and accounting for age, 72% ( n = 18) of ALS subjects had colour vision below the 50th percentile, 52% ( n = 13) had colour vision below the 25th percentile, 24% ( n = 6) had colour vision below the 10th percentile, and 8% ( n = 2) had colour vision below the 2nd percentile. In multivariate models of ln(c-index) and age, the intercept was higher and the slope was flatter in ALS subjects, suggesting that colour vision deficits are more prominent in younger ALS patients. Diffuse colour discrimination deficits are detected in ALS subjects at younger ages than in control subjects. Further study is needed to confirm these findings and to determine if the ALS colour discrimination abnormalities correlate with structural markers of retinal involvement and ALS disease severity.
Abnormalities of the inner and intermediate retinal structures in patients with amyotrophic lateral sclerosis (ALS) have been described using optical coherence tomography and histopathology. Colour vision is a potential marker of these structural changes. The purpose of this study is to test the hypothesis that colour vision impairment is associated with ALS. Monocular (right eye) colour vision was assessed in subjects with definite or probable ALS ( = 25, aged 50-80 years) and control ( = 21, aged 46-89 years) subjects with corrected near visual acuity of at least 20/40 using the L'Anthony D15 color test (desaturated), scored by c-index, a measure of diffuse colour discrimination. Of ALS subjects, 16/25 (64%) had impaired colour vision (c-index >1.8). Comparing with our normal subjects and accounting for age, 72% ( = 18) of ALS subjects had colour vision below the 50th percentile, 52% ( = 13) had colour vision below the 25th percentile, 24% ( = 6) had colour vision below the 10th percentile, and 8% ( = 2) had colour vision below the 2nd percentile. In multivariate models of ln(c-index) and age, the intercept was higher and the slope was flatter in ALS subjects, suggesting that colour vision deficits are more prominent in younger ALS patients. Diffuse colour discrimination deficits are detected in ALS subjects at younger ages than in control subjects. Further study is needed to confirm these findings and to determine if the ALS colour discrimination abnormalities correlate with structural markers of retinal involvement and ALS disease severity.
Abnormalities of the inner and intermediate retinal structures in patients with amyotrophic lateral sclerosis (ALS) have been described using optical coherence tomography and histopathology. Colour vision is a potential marker of these structural changes. The purpose of this study is to test the hypothesis that colour vision impairment is associated with ALS. Monocular (right eye) colour vision was assessed in subjects with definite or probable ALS (n = 25, aged 50-80 years) and control (n = 21, aged 46-89 years) subjects with corrected near visual acuity of at least 20/40 using the L'Anthony D15 color test (desaturated), scored by c-index, a measure of diffuse colour discrimination. Of ALS subjects, 16/25 (64%) had impaired colour vision (c-index >1.8). Comparing with our normal subjects and accounting for age, 72% (n = 18) of ALS subjects had colour vision below the 50th percentile, 52% (n = 13) had colour vision below the 25th percentile, 24% (n = 6) had colour vision below the 10th percentile, and 8% (n = 2) had colour vision below the 2nd percentile. In multivariate models of ln(c-index) and age, the intercept was higher and the slope was flatter in ALS subjects, suggesting that colour vision deficits are more prominent in younger ALS patients. Diffuse colour discrimination deficits are detected in ALS subjects at younger ages than in control subjects. Further study is needed to confirm these findings and to determine if the ALS colour discrimination abnormalities correlate with structural markers of retinal involvement and ALS disease severity.
Author Moss, Heather E.
Boven, Lindsay
Jiang, Qin Li
Author_xml – sequence: 1
  givenname: Lindsay
  surname: Boven
  fullname: Boven, Lindsay
  organization: Department of Ophthalmology and Visual Sciences, University of Illinois College of Medicine
– sequence: 2
  givenname: Qin Li
  surname: Jiang
  fullname: Jiang, Qin Li
  organization: Department of Neurology and Rehabilitation, University of Illinois at Chicago
– sequence: 3
  givenname: Heather E.
  surname: Moss
  fullname: Moss, Heather E.
  email: hemoss@stanford.edu
  organization: Departments of Ophthalmology and Visual Sciences and Neurology and Rehabilitation, University of Illinois at Chicago
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29344070$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1v1DAYhC1URLeFnwDykUu2tmPnQ0iI1S60lRZx4EPcLMd5TQ2JvbUTUP59ne4ugh7g5IOfmbFnztCJ8w4Qek7JkpKKXBBaiIqScskILZc0ZwUV-SO0oCXnmSDF1xO0mJlshk7RWYzfCSFcCPYEnbI655yUZIHcxhozRsBr3_kx4I2NOtjeOjVY77CK-L0KPyBgb_DKGAjgBvzFxlF1-OMUB-jxZopmdPqetw6v-skPwe9urMZbNUCYSd1B8NHGp-ixUV2EZ4fzHH1-9_bT-irbfri8Xq-2meaMDhknbWGoIrQpa1qavGm4ygtD2gaghVowqHRNG85FKWpVtA2lilUgGFEVE8zk5-j13nc3Nj20Or06vUPu0tdUmKRXVv594-yN_OZ_SlEWnBQsGbw8GAR_O0IcZJ-aga5TDvwYJa2rWtS8KvOEvvgz63fIseQEvNoDOnUQAxip7XDfb4q2naREzpPK46RynlQeJk1q8UB9DPif7s1eZ53xoVe_fOhaOaip88EE5bSNMv-3xR3QO7oH
CitedBy_id crossref_primary_10_1080_2326263X_2019_1697163
crossref_primary_10_24075_brsmu_2021_043
crossref_primary_10_2147_EB_S299423
crossref_primary_10_1080_17483107_2020_1754929
crossref_primary_10_1016_j_neurol_2022_11_010
crossref_primary_10_1186_s40478_024_01858_0
crossref_primary_10_1002_mus_26387
crossref_primary_10_1111_ene_16475
Cites_doi 10.4103/0301-4738.99842
10.3109/21678421.2014.951941
10.1038/srep29187
10.1371/journal.pone.0168714
10.1177/1352458513517591
10.1016/j.jns.2011.10.016
10.1016/S0892-0362(97)00046-9
10.1016/S0022-510X(99)00204-X
10.1097/00006324-199310000-00005
10.1016/j.ajo.2015.06.015
10.1212/01.WNL.0000154521.40686.63
10.1016/j.jns.2014.07.022
ContentType Journal Article
Copyright 2017 Taylor & Francis 2017
2017 Taylor & Francis 2017 Taylor & Francis
Copyright_xml – notice: 2017 Taylor & Francis 2017
– notice: 2017 Taylor & Francis 2017 Taylor & Francis
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1080/01658107.2017.1326153
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate L. BOVEN ET AL
EISSN 1744-506X
EndPage 314
ExternalDocumentID PMC5764062
29344070
10_1080_01658107_2017_1326153
1326153
Genre Article
Journal Article
GrantInformation_xml – fundername: National Eye Institute
  grantid: K12 EY02147; K23 EY024345
  funderid: 10.13039/100000053
– fundername: NEI NIH HHS
  grantid: K23 EY024345
– fundername: NEI NIH HHS
  grantid: K12 EY021475
– fundername: ; ;
  grantid: K12 EY02147; K23 EY024345
GroupedDBID ---
00X
03L
0R~
123
29N
4.4
53G
5RE
AALUX
AAMIU
AAPUL
AAQRR
ABBKH
ABDBF
ABEIZ
ABJNI
ABLIJ
ABLJU
ABLKL
ABUPF
ABWVI
ABXYU
ACENM
ACGEJ
ACGFS
ACIEZ
ACUHS
ADBBV
ADCVX
ADRBQ
ADXPE
ADYSH
AECIN
AEOZL
AFKVX
AFRVT
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AJWEG
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
AMDAE
AMPGV
AOIJS
BABNJ
BLEHA
BOHLJ
CCCUG
CS3
DKSSO
DU5
EAP
EBC
EBD
EBS
EJD
EMK
EPL
ESX
F5P
H13
HYE
HZ~
KRBQP
KSSTO
KWAYT
KYCEM
M4Z
O9-
OK1
P2P
RNANH
RPM
RVRKI
TBQAZ
TDBHL
TERGH
TFDNU
TFL
TFW
TUROJ
TUS
UEQFS
V1S
~1N
AAGDL
AAYXX
CITATION
.GJ
5VS
AALIY
AAORF
AAPXX
ABWCV
ABZEW
ACKZS
ACOPL
ACYZI
ADFOM
ADFZZ
AEIIZ
AFLEI
AJVHN
AWYRJ
BRMBE
CAG
COF
CYYVM
CZDIS
DRXRE
DWTOO
JENTW
LJTGL
M44
NPM
NUSFT
QQXMO
TASJS
ZGI
7X8
5PM
ID FETCH-LOGICAL-c421t-40d6f1a01b7917f3bb4a36f0dbeede952e8c91b445759a6db11a28e520a8252f3
ISSN 0165-8107
IngestDate Thu Aug 21 17:50:30 EDT 2025
Fri Jul 11 12:43:19 EDT 2025
Mon Jul 21 05:52:06 EDT 2025
Tue Jul 01 03:36:41 EDT 2025
Thu Apr 24 23:10:05 EDT 2025
Tue May 20 10:47:22 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords desaturated L’Anthony D-15
Amyotrophic lateral sclerosis
retinal disease
colour vision
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c421t-40d6f1a01b7917f3bb4a36f0dbeede952e8c91b445759a6db11a28e520a8252f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
The current affiliation of Heather E. Moss is Departments of Ophthalmology & Neurology and Neurosciences, Stanford University, Palo Alto, California, USA.
PMID 29344070
PQID 1989594873
PQPubID 23479
PageCount 5
ParticipantIDs pubmed_primary_29344070
informaworld_taylorfrancis_310_1080_01658107_2017_1326153
crossref_citationtrail_10_1080_01658107_2017_1326153
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5764062
proquest_miscellaneous_1989594873
crossref_primary_10_1080_01658107_2017_1326153
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-11-02
PublicationDateYYYYMMDD 2017-11-02
PublicationDate_xml – month: 11
  year: 2017
  text: 2017-11-02
  day: 02
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Neuro-ophthalmology (Amsterdam : Aeolus Press. 1980)
PublicationTitleAlternate Neuroophthalmology
PublicationYear 2017
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References CIT0010
CIT0001
CIT0012
CIT0011
Diederich NJ (CIT0013) 1998; 21
CIT0003
CIT0014
CIT0002
CIT0005
CIT0016
CIT0004
CIT0015
CIT0006
CIT0017
Vingrys AJ, King-Smith PE (CIT0008) 1988; 29
22192877 - J Neurol Sci. 2012 Mar 15;314(1-2):97-101
3257208 - Invest Ophthalmol Vis Sci. 1988 Jan;29(1):50-63
26877563 - Trans Am Ophthalmol Soc. 2015 ;113:T12
8247482 - Optom Vis Sci. 1993 Oct;70(10):809-13
24399824 - Mult Scler. 2014 Aug;20(9):1207-16
23514643 - Indian J Ophthalmol. 2013 Mar;61(3):100-3
27383525 - Sci Rep. 2016 Jul 07;6:29187
26116263 - Am J Ophthalmol. 2015 Sep;160(3):547-552.e1
28033389 - PLoS One. 2016 Dec 29;11(12 ):e0168714
9789709 - Clin Neuropharmacol. 1998 Sep-Oct;21(5):289-95
10620653 - J Neurol Sci. 2000 Jan 1;172(1):7-11
15781814 - Neurology. 2005 Mar 22;64(6):992-5
9392781 - Neurotoxicol Teratol. 1997 Nov-Dec;19(6):455-65
25319030 - Amyotroph Lateral Scler Frontotemporal Degener. 2014 Dec;15(7-8):569-80
25086858 - J Neurol Sci. 2014 Oct 15;345(1-2):118-24
References_xml – ident: CIT0014
  doi: 10.4103/0301-4738.99842
– volume: 29
  start-page: 50
  year: 1988
  ident: CIT0008
  publication-title: Invest Ophthalmol Vis Sci
– ident: CIT0001
  doi: 10.3109/21678421.2014.951941
– volume: 21
  start-page: 289
  year: 1998
  ident: CIT0013
  publication-title: Clin Neuropharmacol
– ident: CIT0003
  doi: 10.1038/srep29187
– ident: CIT0005
  doi: 10.1371/journal.pone.0168714
– ident: CIT0016
  doi: 10.1177/1352458513517591
– ident: CIT0004
  doi: 10.1016/j.jns.2011.10.016
– ident: CIT0006
  doi: 10.1016/S0892-0362(97)00046-9
– ident: CIT0012
  doi: 10.1016/S0022-510X(99)00204-X
– ident: CIT0011
  doi: 10.1097/00006324-199310000-00005
– ident: CIT0002
– ident: CIT0017
  doi: 10.1016/j.ajo.2015.06.015
– ident: CIT0015
  doi: 10.1212/01.WNL.0000154521.40686.63
– ident: CIT0010
  doi: 10.1016/j.jns.2014.07.022
– reference: 15781814 - Neurology. 2005 Mar 22;64(6):992-5
– reference: 8247482 - Optom Vis Sci. 1993 Oct;70(10):809-13
– reference: 26116263 - Am J Ophthalmol. 2015 Sep;160(3):547-552.e1
– reference: 28033389 - PLoS One. 2016 Dec 29;11(12 ):e0168714
– reference: 25086858 - J Neurol Sci. 2014 Oct 15;345(1-2):118-24
– reference: 27383525 - Sci Rep. 2016 Jul 07;6:29187
– reference: 22192877 - J Neurol Sci. 2012 Mar 15;314(1-2):97-101
– reference: 9789709 - Clin Neuropharmacol. 1998 Sep-Oct;21(5):289-95
– reference: 26877563 - Trans Am Ophthalmol Soc. 2015 ;113:T12
– reference: 9392781 - Neurotoxicol Teratol. 1997 Nov-Dec;19(6):455-65
– reference: 10620653 - J Neurol Sci. 2000 Jan 1;172(1):7-11
– reference: 24399824 - Mult Scler. 2014 Aug;20(9):1207-16
– reference: 25319030 - Amyotroph Lateral Scler Frontotemporal Degener. 2014 Dec;15(7-8):569-80
– reference: 3257208 - Invest Ophthalmol Vis Sci. 1988 Jan;29(1):50-63
– reference: 23514643 - Indian J Ophthalmol. 2013 Mar;61(3):100-3
SSID ssj0004552
Score 2.1182485
Snippet Abnormalities of the inner and intermediate retinal structures in patients with amyotrophic lateral sclerosis (ALS) have been described using optical coherence...
SourceID pubmedcentral
proquest
pubmed
crossref
informaworld
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 310
SubjectTerms Amyotrophic lateral sclerosis
colour vision
desaturated L'Anthony D-15
Original
retinal disease
Title Diffuse Colour Discrimination as Marker of Afferent Visual System Dysfunction in Amyotrophic Lateral Sclerosis
URI https://www.tandfonline.com/doi/abs/10.1080/01658107.2017.1326153
https://www.ncbi.nlm.nih.gov/pubmed/29344070
https://www.proquest.com/docview/1989594873
https://pubmed.ncbi.nlm.nih.gov/PMC5764062
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEBbtFkovpe-mL1ToLThYsvw6pt1dQsluKSQlNyM5MjEk9rJ2Cttf3xlLduw2sNteRLAlWfF8lkajmW8I-cQ9BctmmDl46gYbFJE6UqfSYSmUoCDwKMNA4YvLYLYUX1f-6mDQb6JLajVJfx2NK_kfqcI1kCtGyf6DZLtO4QL8BvlCCRKG8k4yPs2zbF9h4rktVEcmzdRk6TLpv6smEkc35wBTkwelHv_IK4wYMUzl49ObCle21uNxursp6-vyapOn47nE4GTkCtlqWErzqq_HNpweDlSsN3K7MzxOoKtOd8i7sJa7xtIw1fDvK-PlMUG7g9uzO3wuf5oZD60CVc-VJ7cW7O8wnnneAcJmd58ZldUGUFhzBSyBaIIdWDAD34lsqtt2CjbcVxZq_fnUMz6vf83z1jES-sKu0EMvnMC-GrXXw8LWHuZffkvOl_N5sjhbLe6TBxw2FLy163S88k1upm5wbawXsrAfe8hAixlw3B7bqfzpcNvTYBZPyGO79aBTg6On5J4unpGHF9a54jkpLJyogRMdwonKiho40TKjLZyogRM1cKI9ONG8oD04UQsn2sHpBVmeny2-zBybjsNJBWc1fMjrIGPSZSqEPX7mKSWkF2TuWoGepWOf6yiNmRICc77KYK0YkzzSPndlxH2eeS_JSVEW-jWhLHAz7QqheKxEHPnSY8qL4f34XKl1yEZEtK83SS1XPaZM2SaspbS1UklQKomVyohMumZXhqzltgZxX3ZJ3VjJMpPSJvFuafuxFXQCUzKes8lCl_sqQTdEZEEKoc4rI_huOKBdCwHL7IiEA0h0FZDufXinyDcN7bsfBqB98zd3eO5b8ujw7b0jJ_X1Xr8H5blWHxrc_waQUMIx
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diffuse+Colour+Discrimination+as+Marker+of+Afferent+Visual+System+Dysfunction+in+Amyotrophic+Lateral+Sclerosis&rft.jtitle=Neuro-ophthalmology+%28Amsterdam+%3A+Aeolus+Press.+1980%29&rft.au=Boven%2C+Lindsay&rft.au=Jiang%2C+Qin+Li&rft.au=Moss%2C+Heather+E&rft.date=2017-11-02&rft.issn=0165-8107&rft.volume=41&rft.issue=6&rft.spage=310&rft_id=info:doi/10.1080%2F01658107.2017.1326153&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0165-8107&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0165-8107&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0165-8107&client=summon